Landmark Longitudinal Prostate Cancer Study Released
A new study confirms Cleveland Diagnostics’ IsoPSA test effectively differentiates between low- and high-risk prostate cancer patients.
Read More
Search Results for: prostate cancer
Liquid Biopsy Is an Early Cancer Screening Breakthrough Technology
Liquid biopsy is a groundbreaking, non-invasive method for early cancer detection and monitoring, offering significant clinical potential.
Read More
Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in SEER Specialized Database Release
Decipher Prostate Genomic Classifier data is included in a new SEER Program database, enabling the study of prostate cancer outcomes.
Read More
Telemedicine May Help Reduce Unnecessary Health Tests
Telemedicine adoption may help reduce the use of low-value medical tests, potentially lowering healthcare costs and unnecessary procedures.
Read More
BD Plans to Separate Biosciences and Diagnostic Solutions Business
Summary:BD (Becton, Dickinson and Company) announced its plan to separate its Biosciences and...
Read More